Patent-term extension and the pharmaceutical industry: = Report-Nr.: OTA CIT 143
Saved in:
| Corporate Author: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Washington, D.C.
Office of Technology Assessment
1981
|
| Subjects: | |
| Physical Description: | VIII, 74 S. graph.Darst. |
Staff View
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV006007620 | ||
| 003 | DE-604 | ||
| 005 | 20160125 | ||
| 007 | t | ||
| 008 | 921030s1981 d||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)7766903 | ||
| 035 | |a (DE-599)BVBBV006007620 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-703 |a DE-188 | ||
| 050 | 0 | |a HD9666.5 | |
| 082 | 0 | |a 338.4/5616151/0973 |2 19 | |
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 110 | 2 | |a Congress of the United States (Washington) |e Verfasser |0 (DE-588)16276417-0 |4 aut | |
| 245 | 1 | 0 | |a Patent-term extension and the pharmaceutical industry |b = Report-Nr.: OTA CIT 143 |c Congress of the United States. Off. of Technology Assessment |
| 246 | 1 | 1 | |a Report-Nr.: OTA CIT 143 |
| 264 | 1 | |a Washington, D.C. |b Office of Technology Assessment |c 1981 | |
| 300 | |a VIII, 74 S. |b graph.Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Drug Industry |z United States | |
| 650 | 4 | |a Drugs |z United States |v Patents | |
| 650 | 4 | |a Patents as Topic |z United States | |
| 650 | 4 | |a Pharmaceutical industry |x Technological innovations |z United States | |
| 650 | 4 | |a Technology, Pharmaceutical |x trends |z United States | |
| 650 | 0 | 7 | |a Innovation |0 (DE-588)4027089-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Patent |0 (DE-588)4044874-5 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 689 | 0 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 1 | |a Patent |0 (DE-588)4044874-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 1 | 1 | |a Innovation |0 (DE-588)4027089-0 |D s |
| 689 | 1 | |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-003776436 | ||
Record in the Search Index
| _version_ | 1804120212998455296 |
|---|---|
| any_adam_object | |
| author_corporate | Congress of the United States (Washington) |
| author_corporate_role | aut |
| author_facet | Congress of the United States (Washington) |
| author_sort | Congress of the United States (Washington) |
| building | Verbundindex |
| bvnumber | BV006007620 |
| callnumber-first | H - Social Science |
| callnumber-label | HD9666 |
| callnumber-raw | HD9666.5 |
| callnumber-search | HD9666.5 |
| callnumber-sort | HD 49666.5 |
| callnumber-subject | HD - Industries, Land Use, Labor |
| classification_rvk | QR 525 |
| ctrlnum | (OCoLC)7766903 (DE-599)BVBBV006007620 |
| dewey-full | 338.4/5616151/0973 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/5616151/0973 |
| dewey-search | 338.4/5616151/0973 |
| dewey-sort | 3338.4 75616151 3973 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01760nam a2200469 c 4500</leader><controlfield tag="001">BV006007620</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20160125 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">921030s1981 d||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)7766903</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV006007620</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9666.5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/5616151/0973</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Congress of the United States (Washington)</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)16276417-0</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Patent-term extension and the pharmaceutical industry</subfield><subfield code="b">= Report-Nr.: OTA CIT 143</subfield><subfield code="c">Congress of the United States. Off. of Technology Assessment</subfield></datafield><datafield tag="246" ind1="1" ind2="1"><subfield code="a">Report-Nr.: OTA CIT 143</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">Office of Technology Assessment</subfield><subfield code="c">1981</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 74 S.</subfield><subfield code="b">graph.Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="z">United States</subfield><subfield code="v">Patents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patents as Topic</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Technological innovations</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Technology, Pharmaceutical</subfield><subfield code="x">trends</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Innovation</subfield><subfield code="0">(DE-588)4027089-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Patent</subfield><subfield code="0">(DE-588)4044874-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Patent</subfield><subfield code="0">(DE-588)4044874-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Innovation</subfield><subfield code="0">(DE-588)4027089-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003776436</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV006007620 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T16:38:30Z |
| institution | BVB |
| institution_GND | (DE-588)16276417-0 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003776436 |
| oclc_num | 7766903 |
| open_access_boolean | |
| owner | DE-703 DE-188 |
| owner_facet | DE-703 DE-188 |
| physical | VIII, 74 S. graph.Darst. |
| publishDate | 1981 |
| publishDateSearch | 1981 |
| publishDateSort | 1981 |
| publisher | Office of Technology Assessment |
| record_format | marc |
| spelling | Congress of the United States (Washington) Verfasser (DE-588)16276417-0 aut Patent-term extension and the pharmaceutical industry = Report-Nr.: OTA CIT 143 Congress of the United States. Off. of Technology Assessment Report-Nr.: OTA CIT 143 Washington, D.C. Office of Technology Assessment 1981 VIII, 74 S. graph.Darst. txt rdacontent n rdamedia nc rdacarrier Drug Industry United States Drugs United States Patents Patents as Topic United States Pharmaceutical industry Technological innovations United States Technology, Pharmaceutical trends United States Innovation (DE-588)4027089-0 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Patent (DE-588)4044874-5 gnd rswk-swf USA Pharmazeutische Industrie (DE-588)4045696-1 s Patent (DE-588)4044874-5 s DE-604 Innovation (DE-588)4027089-0 s |
| spellingShingle | Patent-term extension and the pharmaceutical industry = Report-Nr.: OTA CIT 143 Drug Industry United States Drugs United States Patents Patents as Topic United States Pharmaceutical industry Technological innovations United States Technology, Pharmaceutical trends United States Innovation (DE-588)4027089-0 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Patent (DE-588)4044874-5 gnd |
| subject_GND | (DE-588)4027089-0 (DE-588)4045696-1 (DE-588)4044874-5 |
| title | Patent-term extension and the pharmaceutical industry = Report-Nr.: OTA CIT 143 |
| title_alt | Report-Nr.: OTA CIT 143 |
| title_auth | Patent-term extension and the pharmaceutical industry = Report-Nr.: OTA CIT 143 |
| title_exact_search | Patent-term extension and the pharmaceutical industry = Report-Nr.: OTA CIT 143 |
| title_full | Patent-term extension and the pharmaceutical industry = Report-Nr.: OTA CIT 143 Congress of the United States. Off. of Technology Assessment |
| title_fullStr | Patent-term extension and the pharmaceutical industry = Report-Nr.: OTA CIT 143 Congress of the United States. Off. of Technology Assessment |
| title_full_unstemmed | Patent-term extension and the pharmaceutical industry = Report-Nr.: OTA CIT 143 Congress of the United States. Off. of Technology Assessment |
| title_short | Patent-term extension and the pharmaceutical industry |
| title_sort | patent term extension and the pharmaceutical industry report nr ota cit 143 |
| title_sub | = Report-Nr.: OTA CIT 143 |
| topic | Drug Industry United States Drugs United States Patents Patents as Topic United States Pharmaceutical industry Technological innovations United States Technology, Pharmaceutical trends United States Innovation (DE-588)4027089-0 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Patent (DE-588)4044874-5 gnd |
| topic_facet | Drug Industry United States Drugs United States Patents Patents as Topic United States Pharmaceutical industry Technological innovations United States Technology, Pharmaceutical trends United States Innovation Pharmazeutische Industrie Patent USA |
| work_keys_str_mv | AT congressoftheunitedstateswashington patenttermextensionandthepharmaceuticalindustryreportnrotacit143 AT congressoftheunitedstateswashington reportnrotacit143 |